免费获得国外相关药品,最快 1 个工作日回馈药物信息

出境医 / 临床实验 / Influence of Preoperative Fluid Intake on the Onset of Postoperative Acute Kidney Injury (HYDRATE-CSX)

Influence of Preoperative Fluid Intake on the Onset of Postoperative Acute Kidney Injury (HYDRATE-CSX)

Study Description
Brief Summary:
To investigate the influence of preoperative fluid and food intake in cardiac surgery patients on the development of postoperative AKI.

Condition or disease
Thoracic Surgery Acute Kidney Injury Critical Care

Detailed Description:

Acute renal failure (ARF) and the need for renal replacement therapy (RRT) is a major complication after cardiac surgery, associated with mortality and an increased risk to develop end-stage renal disease. Cardiac surgery patients are at increased risk to develop acute kidney failure due to ischaemia-reperfusion injury, cardiopulmonary bypass (CPB) induced inflammation and haemolysis, hemodynamic alterations, vasoconstriction and resulting reduced renal perfusion. According to the current literature, AKI occurs in average in 20-30% after cardiac surgery with an incidence of RRT in 1-5%. Several reviews revealed the literature and concluded that , inter alia, euvolemia, adequate nutrition, the avoidance of nephrotoxic drugs and anemia optimization belong to the most effective prevention strategies.

Patients are instructed to follow the nil per os (NPO) guidelines, including abstinence of clear liquids for >2 hours preoperative as well as fasting time of light foods for > 6 hours and fatty foods for >8 hours prior to surgery. However, these guidelines encourage patients to continue PO hydration until 2 h before surgery in order to optimize the volume status. Besides the fact that NPO lasts in average critically longer than required, surgery delay is a common issue and may lead to an exceedance of NPO up to twice as long as required.

Data about the exact mechanism is still sparse, but preoperative iv hydration may correct or even expand intravascular volume, improve renal perfusion and induce diuresis, stimulate endogenous natriuretic peptides release and inactivate the renin-angiotensin-aldosterone system (RAAS).

Large trials on this very relevant topic in these high risk cardiac surgery patients are absolutely missing. Therefore, this prospective observational study aims to investigate the influence of varied preoperative fluid and food intake in cardiac surgery patients on the development of postoperative AKI.

Study Design
Layout table for study information
Study Type : Observational
Estimated Enrollment : 320 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Influence of Preoperative Fluid Intake on the Onset of Postoperative Acute Kidney Injury in Cardiac Surgery Patients: the HYDRATE-CSX Trial
Actual Study Start Date : April 23, 2019
Estimated Primary Completion Date : January 15, 2020
Estimated Study Completion Date : March 15, 2020
Arms and Interventions
Outcome Measures
Primary Outcome Measures :
  1. Acute kidney injury [ Time Frame: 30 days ]
    Acute kidney injury

  2. Renal replacement therapy [ Time Frame: 7 days postoperative ]
    Renal replacement therapy

  3. Kidney-failure-free days [ Time Frame: 7 days postoperative ]
    defined as the number of days in which a patient had no acute kidney injury and no need for RRT


Secondary Outcome Measures :
  1. Major Adverse Kidney Events [ Time Frame: 30 days ]
    death, dialysis or persistent renal dysfunction

  2. Fluid intake since hospital admission until surgery (ml/h) [ Time Frame: 30 days ]
    Fluid intake since hospital admission until surgery (ml/h)

  3. Calorie intake since hospital admission (kcal/d) [ Time Frame: 30 days ]
    Calorie intake since hospital admission (kcal/d)

  4. Preoperative abstinence of fluids (minutes) [ Time Frame: 30 days ]
    Preoperative abstinence of fluids (minutes)

  5. Preoperative abstinence of food (minutes) [ Time Frame: 30 days ]
    Preoperative abstinence of food (minutes)

  6. ICU length of stay (hours) [ Time Frame: 30 days ]
    ICU length of stay (hours)

  7. Hospital length of stay since surgery (days) [ Time Frame: 30 days ]
    Hospital length of stay since surgery (days)

  8. Mortality until hospital discharge/ 30 days [ Time Frame: up to 30 days ]
    Mortality until hospital discharge/ 30 days


Eligibility Criteria
Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients undergoing elective cardiac surgery at the University Hospital RWTH Aachen
Criteria

Inclusion Criteria:

  • Adult patients (>18 years of age) scheduled to undergo elective cardiac surgery with the use of cardiopulmonary bypass (CPB) and cardioplegic arrest

Exclusion Criteria:

  • Patients not willing to participate or not able to give informed consent
  • Patients receiving contrast agents within 72 hours before surgery
  • Patients with preoperative need for renal replacement therapy
  • Patients receiving an extracorporeal mechanical assist device (e.g. ECLS) or for advanced heart failure therapies (e.g. TAH, VAD) will be excluded.
  • Patients participating in another interventional trial
  • Pregnant or lactating patients
Contacts and Locations

Contacts
Layout table for location contacts
Contact: Julia Krieger +49 241 88726 jukrieger@ukaachen.de

Locations
Layout table for location information
Germany
University Hospital RWTH Aachen Recruiting
Aachen, NRW, Germany, 52074
Contact: Julia Krieger    +4924180 ext 88726    jukrieger@ukaachen.de   
Sponsors and Collaborators
RWTH Aachen University
Investigators
Layout table for investigator information
Principal Investigator: Julia Ney, Dr. med. RWTH Aachen University
Tracking Information
First Submitted Date May 2, 2019
First Posted Date May 6, 2019
Last Update Posted Date September 11, 2019
Actual Study Start Date April 23, 2019
Estimated Primary Completion Date January 15, 2020   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures
 (submitted: May 3, 2019)
  • Acute kidney injury [ Time Frame: 30 days ]
    Acute kidney injury
  • Renal replacement therapy [ Time Frame: 7 days postoperative ]
    Renal replacement therapy
  • Kidney-failure-free days [ Time Frame: 7 days postoperative ]
    defined as the number of days in which a patient had no acute kidney injury and no need for RRT
Original Primary Outcome Measures Same as current
Change History
Current Secondary Outcome Measures
 (submitted: May 3, 2019)
  • Major Adverse Kidney Events [ Time Frame: 30 days ]
    death, dialysis or persistent renal dysfunction
  • Fluid intake since hospital admission until surgery (ml/h) [ Time Frame: 30 days ]
    Fluid intake since hospital admission until surgery (ml/h)
  • Calorie intake since hospital admission (kcal/d) [ Time Frame: 30 days ]
    Calorie intake since hospital admission (kcal/d)
  • Preoperative abstinence of fluids (minutes) [ Time Frame: 30 days ]
    Preoperative abstinence of fluids (minutes)
  • Preoperative abstinence of food (minutes) [ Time Frame: 30 days ]
    Preoperative abstinence of food (minutes)
  • ICU length of stay (hours) [ Time Frame: 30 days ]
    ICU length of stay (hours)
  • Hospital length of stay since surgery (days) [ Time Frame: 30 days ]
    Hospital length of stay since surgery (days)
  • Mortality until hospital discharge/ 30 days [ Time Frame: up to 30 days ]
    Mortality until hospital discharge/ 30 days
Original Secondary Outcome Measures Same as current
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title Influence of Preoperative Fluid Intake on the Onset of Postoperative Acute Kidney Injury
Official Title Influence of Preoperative Fluid Intake on the Onset of Postoperative Acute Kidney Injury in Cardiac Surgery Patients: the HYDRATE-CSX Trial
Brief Summary To investigate the influence of preoperative fluid and food intake in cardiac surgery patients on the development of postoperative AKI.
Detailed Description

Acute renal failure (ARF) and the need for renal replacement therapy (RRT) is a major complication after cardiac surgery, associated with mortality and an increased risk to develop end-stage renal disease. Cardiac surgery patients are at increased risk to develop acute kidney failure due to ischaemia-reperfusion injury, cardiopulmonary bypass (CPB) induced inflammation and haemolysis, hemodynamic alterations, vasoconstriction and resulting reduced renal perfusion. According to the current literature, AKI occurs in average in 20-30% after cardiac surgery with an incidence of RRT in 1-5%. Several reviews revealed the literature and concluded that , inter alia, euvolemia, adequate nutrition, the avoidance of nephrotoxic drugs and anemia optimization belong to the most effective prevention strategies.

Patients are instructed to follow the nil per os (NPO) guidelines, including abstinence of clear liquids for >2 hours preoperative as well as fasting time of light foods for > 6 hours and fatty foods for >8 hours prior to surgery. However, these guidelines encourage patients to continue PO hydration until 2 h before surgery in order to optimize the volume status. Besides the fact that NPO lasts in average critically longer than required, surgery delay is a common issue and may lead to an exceedance of NPO up to twice as long as required.

Data about the exact mechanism is still sparse, but preoperative iv hydration may correct or even expand intravascular volume, improve renal perfusion and induce diuresis, stimulate endogenous natriuretic peptides release and inactivate the renin-angiotensin-aldosterone system (RAAS).

Large trials on this very relevant topic in these high risk cardiac surgery patients are absolutely missing. Therefore, this prospective observational study aims to investigate the influence of varied preoperative fluid and food intake in cardiac surgery patients on the development of postoperative AKI.

Study Type Observational
Study Design Observational Model: Cohort
Time Perspective: Prospective
Target Follow-Up Duration Not Provided
Biospecimen Not Provided
Sampling Method Non-Probability Sample
Study Population Patients undergoing elective cardiac surgery at the University Hospital RWTH Aachen
Condition
  • Thoracic Surgery
  • Acute Kidney Injury
  • Critical Care
Intervention Not Provided
Study Groups/Cohorts Not Provided
Publications * Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status Recruiting
Estimated Enrollment
 (submitted: May 3, 2019)
320
Original Estimated Enrollment Same as current
Estimated Study Completion Date March 15, 2020
Estimated Primary Completion Date January 15, 2020   (Final data collection date for primary outcome measure)
Eligibility Criteria

Inclusion Criteria:

  • Adult patients (>18 years of age) scheduled to undergo elective cardiac surgery with the use of cardiopulmonary bypass (CPB) and cardioplegic arrest

Exclusion Criteria:

  • Patients not willing to participate or not able to give informed consent
  • Patients receiving contrast agents within 72 hours before surgery
  • Patients with preoperative need for renal replacement therapy
  • Patients receiving an extracorporeal mechanical assist device (e.g. ECLS) or for advanced heart failure therapies (e.g. TAH, VAD) will be excluded.
  • Patients participating in another interventional trial
  • Pregnant or lactating patients
Sex/Gender
Sexes Eligible for Study: All
Ages 18 Years and older   (Adult, Older Adult)
Accepts Healthy Volunteers No
Contacts
Contact: Julia Krieger +49 241 88726 jukrieger@ukaachen.de
Listed Location Countries Germany
Removed Location Countries  
 
Administrative Information
NCT Number NCT03938181
Other Study ID Numbers 3CARE_BOÄ_18-004_Hydrate-CSX
Has Data Monitoring Committee No
U.S. FDA-regulated Product
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
IPD Sharing Statement
Plan to Share IPD: No
Responsible Party RWTH Aachen University
Study Sponsor RWTH Aachen University
Collaborators Not Provided
Investigators
Principal Investigator: Julia Ney, Dr. med. RWTH Aachen University
PRS Account RWTH Aachen University
Verification Date September 2019